| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/23/2013 | WO2013073191A1 Therapeutic agent for early delivery or abortion using plasminogen activator inhibitor-1 |
| 05/23/2013 | WO2013073041A1 Method for determining rheumatoid arthritis activity indicator, and biomarker used therein |
| 05/23/2013 | WO2013072868A1 Use of fructokinases and sucrose synthases for increasing cell wall polymers |
| 05/23/2013 | WO2013072832A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/23/2013 | WO2013072587A1 Use of fibromodulin and lumican for increasing muscle mass |
| 05/23/2013 | WO2013072486A1 Mutants of hydantoinase |
| 05/23/2013 | WO2013071883A1 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 05/23/2013 | WO2013071876A1 Constructing method of high-throughput sequencing library and use thereof |
| 05/23/2013 | WO2013071871A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 05/23/2013 | WO2013071440A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | WO2013071356A1 Collagen-like silk genes |
| 05/23/2013 | WO2013071355A1 Soluble mediator |
| 05/23/2013 | WO2013048185A3 Method for forming a reversible protein nanocluster using light in a cell |
| 05/23/2013 | WO2013048163A3 Convenient and efficient purification method for chemically labeled nucleic acids |
| 05/23/2013 | WO2013048153A3 Binding molecule having influenza a virus-neutralizing activity produced from human b cell |
| 05/23/2013 | WO2013048130A3 Binding molecule for neutralizing rabies virus |
| 05/23/2013 | WO2013037841A3 Chimeric non-integrating lentiviral genomes as vaccines against hiv-1 |
| 05/23/2013 | WO2013021389A3 Downregulation of mir-7 for promotion of beta cell differentiation and insulin production |
| 05/23/2013 | WO2012175924A3 Incorporation of substituted lysines into polypeptides |
| 05/23/2013 | WO2012168493A3 Baculoviral dna elements for the expression of recombinant proteins in a host insect |
| 05/23/2013 | WO2012166978A9 Fertilization and fruit size |
| 05/23/2013 | WO2012165854A9 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
| 05/23/2013 | WO2012012443A3 Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
| 05/23/2013 | US20130133113 Constitutive promoters from poplar and uses thereof |
| 05/23/2013 | US20130133111 Compositions and methods of use of mitogen-activated protein kinase kinase kinase |
| 05/23/2013 | US20130133110 Transcriptional activators involved in abiotic stress tolerance |
| 05/23/2013 | US20130133109 Closterovirus vectors and methods |
| 05/23/2013 | US20130133108 Extracts from pirin+ and pirin- plants and uses thereof |
| 05/23/2013 | US20130133107 Genes encoding nematode toxins |
| 05/23/2013 | US20130133106 Isolated polynucleotides and methods and plants using same for regulating plant acidity |
| 05/23/2013 | US20130133104 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt5 polypeptides and homologs thereof |
| 05/23/2013 | US20130133103 Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants |
| 05/23/2013 | US20130133101 Plants resistant to pathogens and methods for production thereof |
| 05/23/2013 | US20130133100 Radish cultivar e66v70336 |
| 05/23/2013 | US20130133093 Recombinant constructs and transgenic fluorescent ornamental fish therefrom |
| 05/23/2013 | US20130133092 Sequence-specific dna recombination in eukaryotic cells |
| 05/23/2013 | US20130131331 Cancer-cell-specific cytostatic agent |
| 05/23/2013 | US20130131330 Bidirectional promoters in nannochloropsis |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130131312 Peptide conjugated, inosine-substituted antisense oligomer compound and method |
| 05/23/2013 | US20130131154 Nonviral Gene Delivery Vector Iopamidol, Protamine, Ethiodized Oil Reagent (Viper) |
| 05/23/2013 | US20130131150 Antisense Formulation |
| 05/23/2013 | US20130131149 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna |
| 05/23/2013 | US20130131145 COMPOSITIONS AND METHODS FOR ALTERING RNAi |
| 05/23/2013 | US20130131144 GDE Compositions and Methods |
| 05/23/2013 | US20130131141 Reduced size self-delivering rnai compounds |
| 05/23/2013 | US20130131140 Treatment of diabetes and disorders associated with visceral obesity with inhibitors of human arachidonate 12 lipoxygenase and arachidonate 15-lipoxygenase |
| 05/23/2013 | US20130130940 Multi-targeted priming for genome-wide gene expression assays |
| 05/23/2013 | US20130130938 Oligonucleotide library encoding randomised peptides |
| 05/23/2013 | US20130130389 Novel promoter for use in transformation of algae |
| 05/23/2013 | US20130130388 Methods of Modifying Eurakyotic Cells |
| 05/23/2013 | US20130130387 Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles |
| 05/23/2013 | US20130130386 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
| 05/23/2013 | US20130130385 Surface markers and uses thereof for rapid stable cell line generation and gene amplification |
| 05/23/2013 | US20130130372 Enhanced expression and stability regions |
| 05/23/2013 | US20130130370 MicroRNA and Methods for Inhibiting Same |
| 05/23/2013 | US20130130347 Constructs and methods for the assembly of biological pathways |
| 05/23/2013 | US20130130344 Microorganism variants having hydrocarbon producing ability and method for producing hydrocarbon using the same |
| 05/23/2013 | US20130130342 Yeast Strain for Production of Four Carbon Alcohols |
| 05/23/2013 | US20130130340 Biosynthesis of caffeic acid and caffeic acid derivatives by recombinant microorganisms |
| 05/23/2013 | US20130130313 METHOD OF SYNTHESIZING A SUPPRESSOR tRNA, DNA CONSTRUCT AND USE THEREOF FOR PRODUCING A NON-NATURAL AMINO ACID-INCORPORATED PROTEIN |
| 05/23/2013 | US20130130252 Identification of pold2 sequences |
| 05/23/2013 | US20130130251 Identification of snare ykt6 sequences |
| 05/23/2013 | US20130130250 Isolated glucokinase genomic polynucleotide fragments from chromosome 7 |
| 05/23/2013 | US20130130247 Kits and Methods for Assessing Skin Health |
| 05/23/2013 | US20130130233 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 05/23/2013 | US20130130231 Bioinformatically detectable group of novel viral regulatory genes and uses thereof |
| 05/23/2013 | US20130129862 Barley lipoxygenase 1 gene, method of selecting barley variety, material of malt alcoholic drinks and process for producing malt alcoholic drink |
| 05/23/2013 | US20130129769 Method for making targeted therapeutic agents directed to soluble targets |
| 05/23/2013 | US20130129752 Targeted delivery to leukocytes using protein carriers |
| 05/23/2013 | US20130129719 Her2 nucleic acid aptamers |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129714 Prevention and treatment of cast nephropathy |
| 05/23/2013 | US20130129697 Enhanced Staphylolytic Activity of the Staphylococcus aureus Bacteriophage vB_SauS-philPLA88 Virion-Associated Peptidoglycan Hydrolase HydH5: Fusions, Deletions and Synergy with LysH5 |
| 05/23/2013 | US20130129629 Modulation of bcl11a for treatment of hemoglobinopathies |
| 05/23/2013 | DE102006020463B4 Verfahren zum Entfernen von Nukleinsäuren aus einer Flüssigkeit, Verfahren zur Herstellung von Adsorberelementen und Verwendung von Membranadsorbermaterial-Verschnitt A method of removing nucleic acids from a fluid, method for producing adsorber and using Membranadsorbermaterial-blend |
| 05/23/2013 | CA2856289A1 Modified rnai agents |
| 05/23/2013 | CA2856288A1 Nucleic acid fragment binding to target protein |
| 05/23/2013 | CA2856244A1 Use of fructokinases and sucrose synthases for increasing cell wall polymers |
| 05/23/2013 | CA2856243A1 Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases |
| 05/23/2013 | CA2856134A1 Selective detection of norovirus |
| 05/23/2013 | CA2856127A1 Mutants of hydantoinase |
| 05/23/2013 | CA2856117A1 Auto-recognizing therapeutic rna/dna chimeric nanoparticles (np) |
| 05/23/2013 | CA2856116A1 Therapeutic rna switches compositions and methods of use |
| 05/23/2013 | CA2856083A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 05/23/2013 | CA2856016A1 Agent for treating fibrosis of the intestine |
| 05/23/2013 | CA2855953A1 Quantitative, highly multiplexed detection of nucleic acids |
| 05/23/2013 | CA2855933A1 Methods and compositions for isolating, identifying and characterizing monocot plastidic accase herbicide tolerant mutations using a model system |
| 05/23/2013 | CA2855675A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | CA2855653A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | CA2855152A1 Collagen-like silk genes |
| 05/23/2013 | CA2854939A1 Gamma-pna miniprobes for fluorescent labeling |
| 05/23/2013 | CA2854882A1 Medicament for therapeutic treatment and/or improvement of sepsis |
| 05/23/2013 | CA2854819A1 Modified dna-binding proteins and uses thereof |
| 05/23/2013 | CA2854809A1 Compositions and methods for treating autoimmune and inflammatory disorders |
| 05/23/2013 | CA2852617A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/23/2013 | CA2852133A1 Soluble mediator |
| 05/22/2013 | EP2594941A1 Method for fabricating microarrays of soft materials |
| 05/22/2013 | EP2594647A2 Plants with increased yield |
| 05/22/2013 | EP2594646A2 Plant with increased yield |